Polio Vaccine Market 2019-2028
New Study Reports “Polio Vaccine Market 2019 Global Market Opportunities, Challenges, Strategies and Forecasts 2028” Added in Wiseguyreports.com.
Polio vaccines are the vaccines used to prevent poliomyelitis or polio. The Polio vaccine is recommended for children aged 2 months, 4 months, 6-18 months and age ranging from 4 to 6 years. The WHO advocates that all children should be fully vaccinated against polio. Polio vaccines can be used as a single drug or mixed with a mixture of drugs. The combined polio vaccine drugs are used to fight against Diptheria, tetanus, and infections caused by the hepatitis B virus.
A global organization like the UNICEF supplies vaccines that have reached almost 45% of the world’s children under five years old to improve child survival. It has also been reported that there is a reduction in the number of polio cases each year from 350,000 in 1988 to 33 in 2018. The polio vaccines should be provided to pregnant women because the attack rate of polio ids greater in pregnant versus the non-pregnant women. For global polio eradication, the interruption of person-to-person transmission is very important.
The 2013-2028 report on Global Polio Vaccine Market provides a detailed analysis of the polio vaccine market from 2013-2028 and forecasts the extension of the market from 2019-2028. The report also covers the volume, market share, price, revenue, historical data and upcoming perspectives in the polio vaccine market. The social welfare organizations like the WHO, UNICEF, and other member nations have started an initiative called Global Polio Eradication Initiative (GPEI) to eradicate the poliovirus globally and spread awareness for the global consumption of polio vaccine.
Important Key Players Analysis: Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals and more.
Request for Free Sample Report of “Polio Vaccine” Market @ https://www.wiseguyreports.com/sample-request/4527192-2013-2028-report-on-global-polio-vaccine-market
On the basis of market segmentation by type, the global polio vaccine market can be split into the Oral Polio Vaccine (OPV) and Inactivated Polio Vaccine (IPV). Both of these vaccines are very safe and are given during pregnancy or to those who have HIV/AIDS. These vaccines have eliminated polio from almost every country. The IPV is the only polio vaccine that has been endorsed in the United States since 2000. And depending on the market segmentation by application, the global polio vaccine market can be categorized into Private and Public. Whereas based on the market segmentation by Sales Channels, the global polio vaccine market can be classified into Distribution and Direct Channel.
Countries like Canada, Mexico, United States, Colombia, UK, France, Argentina, Brazil, Australia, Russia, Italy, Spain, Chile, Egypt, Nigeria, South Africa, Saudi Arabia, Korea, India, are among the major hubs for the consumption of polio vaccines. The competition among the key players in the polio vaccine market has increased due to the reduction in the fundings by the governmental organizations which has further led to the expansion of the private companies in the global market. The report analyses the rising awareness of poliovirus diseases among the global population and the growing need for polio vaccinations among developing nations that have led to the vibrant growth of the polio vaccines market.
Polio Vaccine Manufacturers
Polio Vaccine Distributors/Traders/Wholesalers
Polio Vaccine Subcomponent Manufacturers
If you have any special requirements, please let us know and we will offer you the report as you want.
Complete Report Details@ https://www.wiseguyreports.com/reports/4527192-2013-2028-report-on-global-polio-vaccine-market
The United Nations Children’s Emergency Fund (UNICEF) in collaboration with the Philippine Department of Health (DOH) is supporting the polio vaccine campaign in the city of Manila, Davao, and Marawi. The WHO and UNICEF will cover almost 1.8 million children with their Polio Vaccine Campaign for children under 5 years old.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)